Source: Health Canada shortage reports · Updated Sep 23, 2026
Rivastigmine has no current shortage reported in Canada. It has been in shortage before; the history is below.
A medication used to treat symptoms of dementia in Alzheimer's and Parkinson's disease.
Products affected
0 / 30
Reports on file
92
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
MED-RIVASTIGMINE
1.5MG · CAPSULE · GENERIC MEDICAL PARTNERS INC
DIN 02401614 · ended Aug 17, 2026 · Demand increase for the drug.
Resolved
MYLAN-RIVASTIGMINE PATCH 5
4.6MG · PATCH · MYLAN PHARMACEUTICALS ULC
DIN 02423413 · ended Mar 19, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ RIVASTIGMINE PATCH 10
9.5MG · PATCH · SANDOZ CANADA INCORPORATED
DIN 02426307 · ended Feb 2, 2026 · Disruption of the manufacture of the drug.
Resolved
EXELON
2MG · SOLUTION · KNIGHT THERAPEUTICS INC.
DIN 02245240 · ended Dec 10, 2025 · Demand increase for the drug.
Resolved
EXELON
4.5MG · CAPSULE · KNIGHT THERAPEUTICS INC.
DIN 02242117 · ended Nov 10, 2025 · Demand increase for the drug.
Resolved
EXELON
3MG · CAPSULE · KNIGHT THERAPEUTICS INC.
DIN 02242116 · ended Nov 10, 2025 · Demand increase for the drug.
Resolved
EXELON
1.5MG · CAPSULE · KNIGHT THERAPEUTICS INC.
DIN 02242115 · ended Dec 1, 2025 · Demand increase for the drug.
Resolved
JAMP RIVASTIGMINE
1.5MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02485362 · ended Aug 1, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP RIVASTIGMINE
4.5MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02485389 · ended Aug 1, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP RIVASTIGMINE
4.5MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02485389 · ended Aug 1, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP RIVASTIGMINE
3MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02485370 · ended Aug 1, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP RIVASTIGMINE
3MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02485370 · ended Aug 1, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Rivastigmine. Health Canada has 92 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Rivastigmine is classified under “ANTI-DEMENTIA DRUGS” (ATC N06DA).
Recent changes
Sep 23, 2026
Shortage resolved
Common questions
What is Rivastigmine used for?
A medication used to treat symptoms of dementia in Alzheimer's and Parkinson's disease.
When will Rivastigmine be back in stock in Canada?
Rivastigmine has no active shortage; supply is normal per Health Canada reports.
Why is Rivastigmine in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.